| Followers | 63 |
| Posts | 2793 |
| Boards Moderated | 0 |
| Alias Born | 07/08/2014 |
Wednesday, November 29, 2023 2:56:39 PM
Sure is
Recent PCSA News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 09:12:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 09:17:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 09:11:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 09:09:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 09:08:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 09:06:41 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 02/23/2026 04:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/19/2026 09:05:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 10:07:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 10:05:30 PM
- Processa Pharmaceuticals to Attend 44th Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/12/2026 02:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/07/2026 01:30:50 PM
- Processa Pharmaceuticals Completes Enrollment of 20th Patient for Formal Interim Analysis in Phase 2 NGC-Cap Breast Cancer Study • GlobeNewswire Inc. • 01/05/2026 02:15:00 PM
- Processa Pharmaceuticals Shares Surge on Encouraging Cancer Trial Update • IH Market News • 12/17/2025 03:10:16 PM
- Processa Pharmaceuticals Provides Clinical Update on Phase 2 Study in Metastatic Breast Cancer • GlobeNewswire Inc. • 12/17/2025 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/15/2025 04:00:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2025 09:07:39 PM
- Processa Pharmaceuticals Announces Poster Presentation of Adaptive Phase 2/3 PCS499 Study in FSGS at ASN Kidney Week 2025 • GlobeNewswire Inc. • 11/05/2025 02:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2025 08:41:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2025 08:39:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2025 08:36:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2025 08:33:01 PM
